治疗应用的剂量测量软件:当前能力和未来前景
Adam L Kesner1, Julia Brosch-Lenz2, Jonathan Gear3
1Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
概括
本综述强调了剂量计软件在放射性药物治疗中的关键作用,以实现个性化治疗和患者安全. 它强调需要标准化,高级功能和协作来提高治疗疗效.
科学领域:
- 医学物理 医学物理
- 核医学是一种核医学.
- 放射性药物疗法是一种放射性药物疗法.
背景情况:
- 剂量测量对于个性化的放射性药物疗法至关重要,用于治疗规划和安全,计算吸收剂量.
- 治疗放射性药物的不断扩大的领域需要先进的剂量测量软件来优化治疗疗效.
研究的目的:
- 审查用于放射性药物治疗的剂量计软件的当前和未来功能.
- 确定对剂量测量软件的标准化,先进建模和改进的不确定性量化需求.
- 倡导开放的数据集和供应商和最终用户的协作,以提高整合和有效性.
主要方法:
- 对当前剂量计软件能力的文献综述.
- 对未来剂量测量软件开发的基本特征的分析.
- 讨论软件进步和现场集成的机会.
主要成果:
- 目前的剂量测量软件至关重要,但需要跨平台的标准化,以便准确的剂量计算.
- 未来的软件应该包含生物有效剂量建模和增强的不确定性量化.
- 标准化和协作是提高放射性药物疗法疗效的关键.
结论:
- 剂量测量软件的标准化对于放射性药物治疗中一致和准确的剂量计算至关重要.
- 需要在软件方面的进步,包括生物有效剂量建模和不确定性量化.
- 开放数据基础设施和协作努力将推动更大的集成和有效性在现场.
相关概念视频
Drug Concentrations: Measurements
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Plasma —...
Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...


